Home
Dashboard
Curated content
Themes
Innovations
Key Innovators
Key Innovators - Universities
European Innovation Council
Funding rounds
Companies
Corporates
Investors
Jobs
Support Organisations
Events
Investment heatmap
Matching tool
Companies
Hangzhou Chance Pharmaceuticals
Save
Hangzhou Chance Pharmaceuticals
A clinical-stage biotechnology company focusing on discovering.
Launch date
2015
Employees
2-10 people
Market cap
-
Enterprise valuation
$120—180m
(Dealroom.co estimates Oct 2021.)
Hangzhou City Zhejiang (HQ)
https://chancepharmaceuticals.com
https://www.linkedin.com/company/chance-pharmaceuticals/
B2B
saas
commission
health
health platform
biotechnology
hard tech
biotechnology
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Financials
Estimates*
Edit
Revenues, earnings & profits over time
USD
2021
2022
2023
Revenues
<1m
<1m
<1m
Hangzhou Chance Pharmaceuticals funding
Hangzhou Chance Pharmaceuticals investors
Edit
Date
Investors
Amount
Round
Apr 2016
Delian Capital
CNY10.0m
Angel
Jan 2018
Kaitai Capital
Delian Capital
Shenzhen Guozhong Venture Capital Management
CNY55.0m
Series A
Jun 2020
Yipinhong Pharmaceutical
CNY80.0m
Series B
Oct 2021
HEDA Ventures
Shenzhen Guozhong Venture Capital Management
Lapam Capital
CMS
$30.0m
Series C
Total Funding
$49.9m
Related Content
Recent News about Hangzhou Chance Pharmaceuticals
Edit